Collagen-Based Tissue Engineering Strategies for Vascular Medicine

Area of Science:

• Biomaterials Science
• Cardiovascular Research
• Regenerative Medicine

Background:

• Cardiovascular diseases (CVDs) are the leading cause of death globally, with atherosclerosis necessitating vascular grafts.
• Current polymeric vascular grafts face high failure rates due to thrombosis and neointima hyperplasia.
• Accelerated endothelial cell (EC) regeneration is critical for improving graft patency and reducing adverse outcomes.

Purpose of the Study:

• To review the current applications of collagen-based strategies in vascular graft functionalization.
• To explore collagen as a coating material and drug delivery system for promoting re-endothelialization.
• To discuss the potential of collagen in vascular tissue engineering and as in vitro models.

Main Methods:

• Review of literature on collagen's use in vascular graft coatings.
• Analysis of collagen-based drug delivery systems for controlled release of pro-endothelialization factors.
• Evaluation of collagen scaffolds in vascular tissue engineering and disease modeling.

Main Results:

• Collagen coatings provide binding sites for ECs and act as sealants, improving graft integration.
• Collagen-based drug delivery systems protect therapeutic molecules and control their release, enhancing vascular cell function.
• Collagen shows potential as a scaffold for vascular tissue engineering and as a model for studying cardiovascular diseases.

Conclusions:

• Collagen-based strategies, including coatings and drug delivery systems, are vital for improving vascular graft performance.
• Collagen offers a versatile biomaterial for enhancing re-endothelialization and developing advanced cardiovascular therapies.
• Further research into collagen's mechanical properties is needed for its clinical translation in tissue engineering.